Information  X 
Enter a valid email address

Lipoxen PLC (XEN)

  Print      Mail a friend

Thursday 27 May, 2010

Lipoxen PLC

Director/PDMR Shareholding

RNS Number : 6705M
Lipoxen PLC
27 May 2010

For immediate release

27 May 2010





Lipoxen plc

 ("Lipoxen" or the "Company")


Director dealings


The Company was informed on 27 May 2010 that FDS Pharma Associates and its related parties disposed of 190,266 ordinary shares of 0.5p each ("Ordinary Shares") at 9.78 pence each on 29 December 2009.


Following these disposals FDS Pharma Associates and its related parties have an interest in Lipoxen of 41,965,050 Ordinary Shares, representing 24.41 per cent of the issued Ordinary Share capital in the Company.




Lipoxen plc

+44 (0)20 7389 5015

M. Scott Maguire, Chief Executive Officer

Singer Capital Markets (nominated adviser)

+44 (0)20 3205 7500

Jeff Keating / Claes Spång

Buchanan Communications

+44 (0)20 7466 5000

Lisa Baderoon / Catherine Breen


This information is provided by RNS
The company news service from the London Stock Exchange